Literature DB >> 9348216

Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb.

V C Russo1, L A Bach, A J Fosang, N L Baker, G A Werther.   

Abstract

A family of six insulin-like growth factor binding proteins (IGFBPs) bind IGF-I and modulate its biological activity. IGFBPs may bind to macromolecules on the cell surface or pericellular extracellular matrix, and this interaction may modulate their effect on IGF activity. To date, little is known about the specificity of IGFBPs in the regulation of IGF action in the brain. We therefore explored whether IGFBPs were associated with cell membrane or extracellular matrix components in the rat brain. IGF-I binding sites with the characteristics of an IGFBP were found in the olfactory bulb mitral cell layer. This IGFBP was identified as IGFBP-2 by immunoprecipitation of both solubilized membrane preparations and cross-linked 125I-IGF: IGFBP complexes. While binding of IGFBP-2 to cell membranes was unaffected by RGD-containing peptide, it was inhibited by high salt concentration, suggesting interaction with proteoglycans. IGFBP-2 bound in vitro to the glycosaminoglycans chondroitin-4 and -6-sulfate, keratan sulfate, and heparin. IGFBP-2 also bound the proteoglycan aggrecan, an effect reduced by digestion of its glycosaminoglycans. Binding of IGFBP-2 to chondroitin-6-sulfate decreased the binding affinity of IGFBP-2 for IGF-I approximately 3-fold. Finally, an IGFBP-2 antibody coimmunoprecipitated IGFBP-2 and an approximately 200 kDa proteoglycan containing chondroitin-sulfate side chains from the rat olfactory bulb, providing definitive evidence for IGFBP-2 binding to olfactory bulb proteoglycans. These findings indicate that IGFBP-2 binds to proteoglycans in cell membranes of the rat olfactory bulb. Because we have previously shown that IGFs are highly expressed in the rat olfactory bulb, cell associated IGFBP-2 may have an important role in directing IGFs to specific sites in this brain region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348216     DOI: 10.1210/endo.138.11.5472

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.

Authors:  H Yu; J Mistry; M J Nicar; M J Khosravi; A Diamandis; J van Doorn; A Juul
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 3.  What's new in the IGF-binding proteins?

Authors:  Steven A Rosenzweig
Journal:  Growth Horm IGF Res       Date:  2004-10       Impact factor: 2.372

4.  Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.

Authors:  Petra Wiedmer; Franziska Schwarz; Birgit Große; Nancy Schindler; Armin Tuchscherer; Vincenzo C Russo; Matthias H Tschöp; Andreas Hoeflich
Journal:  J Cell Commun Signal       Date:  2015-02-08       Impact factor: 5.782

5.  Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish.

Authors:  C Duan; J Ding; Q Li; W Tsai; K Pozios
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton.

Authors:  Masanobu Kawai; Anne C Breggia; Victoria E DeMambro; Xinchun Shen; Ernesto Canalis; Mary L Bouxsein; Wesley G Beamer; David R Clemmons; Clifford J Rosen
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

7.  Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.

Authors:  Abigail H Conrad; Yuntao Zhang; Elena S Tasheva; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

8.  IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.

Authors:  S W Yau; V C Russo; I J Clarke; F R Dunshea; G A Werther; M A Sabin
Journal:  Int J Obes (Lond)       Date:  2014-11-05       Impact factor: 5.095

9.  Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3.

Authors:  Toshiro Migita; Tadahito Narita; Reimi Asaka; Erika Miyagi; Hiroko Nagano; Kimie Nomura; Masaaki Matsuura; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Hiroyuki Seimiya; Yuichi Ishikawa
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

10.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.